Integrated BioPharma, Inc. (INBP)
0.167
-0.01
(-7.22%)
USD |
OTCM |
Aug 24, 16:00
Integrated BioPharma Profit Margin (Quarterly) : -8.28% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -8.28% |
| December 31, 2025 | -6.76% |
| September 30, 2025 | 0.97% |
| June 30, 2025 | -1.26% |
| March 31, 2025 | 4.38% |
| December 31, 2024 | 0.92% |
| September 30, 2024 | 1.90% |
| June 30, 2024 | 2.10% |
| March 31, 2024 | 2.17% |
| December 31, 2023 | -3.32% |
| September 30, 2023 | -0.46% |
| June 30, 2023 | 0.31% |
| March 31, 2023 | 0.12% |
| December 31, 2022 | -0.45% |
| September 30, 2022 | -0.28% |
| June 30, 2022 | 11.26% |
| March 31, 2022 | 5.10% |
| December 31, 2021 | 7.06% |
| September 30, 2021 | 4.05% |
| June 30, 2021 | 26.42% |
| March 31, 2021 | 7.27% |
| December 31, 2020 | 8.59% |
| September 30, 2020 | 6.86% |
| June 30, 2020 | 14.05% |
| March 31, 2020 | 6.87% |
| Date | Value |
|---|---|
| December 31, 2019 | 6.75% |
| September 30, 2019 | 2.74% |
| June 30, 2019 | 2.65% |
| March 31, 2019 | 6.55% |
| December 31, 2018 | 2.05% |
| September 30, 2018 | 1.54% |
| June 30, 2018 | 6.51% |
| March 31, 2018 | 3.67% |
| December 31, 2017 | -3.22% |
| September 30, 2017 | -1.83% |
| June 30, 2017 | 13.66% |
| March 31, 2017 | 2.23% |
| December 31, 2016 | -0.62% |
| September 30, 2016 | 5.12% |
| June 30, 2016 | 6.56% |
| March 31, 2016 | 0.30% |
| December 31, 2015 | -0.60% |
| September 30, 2015 | 2.55% |
| June 30, 2015 | -1.23% |
| March 31, 2015 | -1.10% |
| December 31, 2014 | 5.32% |
| September 30, 2014 | 4.70% |
| June 30, 2014 | -1.39% |
| March 31, 2014 | -5.98% |
| December 31, 2013 | 4.52% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Medifast, Inc. | -4.06% |
| BioForce Nanosciences Holdings, Inc. | -- |
| Skinvisible, Inc. | -5.11K% |
| Nevis Brands, Inc. | -62.39% |
| Skinhealth Systems, Inc. | -3.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.28% |
| Return on Assets | -6.55% |
| Return on Invested Capital | -7.75% |
| Gross Profit Margin (Quarterly) | -2.73% |
| Operating Margin (Quarterly) | -10.74% |
| Return on Net Operating Assets | -9.87% |